Compare Banco Santander SA (SAN) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Santander SA vs Summit Therapeutics Inc — how do they compare? Banco Santander SA trades at $13.7 (market cap $191.46B), while Summit Therapeutics Inc trades at $14.58 (market cap $10.48B). The key difference: Banco Santander SA is far larger — about 18.3× Summit Therapeutics Inc's market cap, and Banco Santander SA pays a 2.09% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SAN | SMMT | |
|---|---|---|
Market Cap | $191.46B | $10.48B |
Sector | Financials | Health |
52-Week High | $14.37 | $29.32 |
52-Week Low | $8.40 | $13.05 |
Dividend Yield | 2.09% | — |
Enterprise Value | — | $9.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
